LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced it is integrating with LillyDirect pharmacy provider, Gifthealth, to offer streamlined access of single-dose vials of Lilly’s prescription obesity treatment Zepbound^® (tirzepatide) to eligible LifeMD patients. Integration with the LillyDirect^® self-pay pharmacy channel will provide a seamless solution to a patient’s Zepbound fulfillment journey while continuing to offer more accessible pricing and direct shipment to patients.

Read more at globenewswire.com